New foliar fungicide offers strong disease control for major Canadian crops
Vive Crop Protection has announced the Canadian registration of Phobos™ FC360, a new foliar fungicide developed to provide stronger disease protection and improved on-leaf performance for farmers. The product will be available for growers across Canada beginning in the 2026 growing season.
Phobos™ FC360 uses Vive’s Allosperse™ Delivery Technology and contains Prothioconazole, a Group 3 fungicide widely used for disease management in crops. The product is approved for several important Canadian crops including canola, spring wheat, winter wheat, barley, chickpeas, pulses, and other specialty crops.
One of the key advantages of Phobos™ FC360 is its ability to perform well under challenging field conditions. Farmers across Canada often face unpredictable weather and strong disease pressure. The new fungicide is designed to remain evenly distributed across the leaf surface, helping provide reliable disease protection.
The product is also easy to use in spray programs. It can be mixed with liquid fertilizers, micronutrients, and other crop inputs, allowing farmers to simplify their application process. Unlike some products that may clump or form ridges on leaves, Phobos™ FC360 spreads evenly and stays where it is applied. This improves coverage and reduces the risk of rain washing the product.
"Canadian growers are looking for solutions that deliver consistent disease control without adding complexity to their spray programs," said Wade Clarke, National Business Development Manager, Canada, Vive Crop Protection. "Phobos™ FC360 brings a clear application advantage, stronger on-leaf retention, even coverage, and proven performance across Canada. We're excited to provide growers with another tool that helps protect yield potential and maximize the value of every acre."
Field trials conducted in 2025 across several regions showed strong results. In canola, the fungicide effectively controlled Sclerotinia stem rot and performed as well as or better than leading industry standards in both disease control and yield. In winter wheat trials in Ontario, the product provided strong control of Fusarium Head Blight and helped reduce DON levels.
In spring wheat trials in Manitoba, Phobos™ FC360 produced high yields and reduced foliar diseases such as Septoria, tan spot, and leaf rust. Barley trials also showed lower levels of Fusarium Head Blight and competitive yields compared with other products.
Additional research in Nova Scotia demonstrated improved disease protection and higher yields in low-bush blueberry crops.
"The registration of Phobos™ FC360 marks another step in Vive's commitment to delivering advanced solutions for Canadian agriculture," said Darren Anderson, CEO of Vive Crop Protection. "Canadian growers need products that perform consistently and Phobos™ FC360 is designed to do just that."
The registration of Phobos™ FC360 highlights the continued development of advanced crop protection technologies designed to help farmers protect yields, manage disease risks, and improve crop performance across Canadian growing regions.
Photo Credit: Vive-Crop-Protection-logo